These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9241246)

  • 1. 2',5'-linked oligo-3'-deoxyribonucleoside phosphorothioate chimeras: thermal stability and antisense inhibition of gene expression.
    Bhan P; Bhan A; Hong M; Hartwell JG; Saunders JM; Hoke GD
    Nucleic Acids Res; 1997 Aug; 25(16):3310-7. PubMed ID: 9241246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
    Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
    Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
    Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helix-stabilizing compounds CC-1065 and U-71,184 bind to RNA-DNA and DNA-DNA duplexes containing modified internucleotide linkages and stabilize duplexes against thermal melting.
    Kim DY; Shih DS; Cho DY; Swenson DH
    Antisense Res Dev; 1995; 5(1):49-57. PubMed ID: 7542048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
    Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
    Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
    Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
    Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.
    Furdon PJ; Dominski Z; Kole R
    Nucleic Acids Res; 1989 Nov; 17(22):9193-204. PubMed ID: 2555787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.
    Peng Ho S; Livanov V; Zhang W; Li J; Lesher T
    Brain Res Mol Brain Res; 1998 Nov; 62(1):1-11. PubMed ID: 9795101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic NMR structures of [Rp]- and [Sp]-phosphorothioated DNA-RNA hybrids: is flexibility required for RNase H recognition?
    Tonelli M; Ulyanov NB; Billeci TM; Karwowski B; Guga P; Stec WJ; James TL
    Biophys J; 2003 Oct; 85(4):2525-38. PubMed ID: 14507715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate oligonucleotide-directed triple helix formation.
    Hacia JG; Wold BJ; Dervan PB
    Biochemistry; 1994 May; 33(18):5367-9. PubMed ID: 8180158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes.
    Crooke ST; Lemonidis KM; Neilson L; Griffey R; Lesnik EA; Monia BP
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):599-608. PubMed ID: 8526876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.
    Kandimalla ER; Manning A; Zhao Q; Shaw DR; Byrn RA; Sasisekharan V; Agrawal S
    Nucleic Acids Res; 1997 Jan; 25(2):370-8. PubMed ID: 9016567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.
    Xodo L; Alunni-Fabbroni M; Manzini G; Quadrifoglio F
    Nucleic Acids Res; 1994 Aug; 22(16):3322-30. PubMed ID: 8078767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA.
    Weidner DA; Busch H
    Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin.
    Compagno D; Lampe JN; Bourget C; Kutyavin IV; Yurchenko L; Lukhtanov EA; Gorn VV; Gamper HB; Toulmé JJ
    J Biol Chem; 1999 Mar; 274(12):8191-8. PubMed ID: 10075723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of phosphorothioate-modified oligonucleotide resistance to 3'-exonuclease using capillary electrophoresis.
    Gilar M; Belenky A; Budman Y; Smisek DL; Cohen AS
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 714(1):13-20. PubMed ID: 9746230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is irrelevant cleavage the price of antisense efficacy?
    Stein CA
    Pharmacol Ther; 2000 Mar; 85(3):231-6. PubMed ID: 10739877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.